Antenatal Hydronephrosis (Urinary Tract Dilation) Clinical Presentation

1. Elder JS. Antenatal hydronephrosis. Fetal and neonatal management. Pediatr Clin North Am. 1997 Oct. 44(5):1299-321. [Medline].

2. Johnson CE, Elder JS, Judge NE, Adeeb FN, Grisoni ER, Fattlar DC. The accuracy of antenatal ultrasonography in identifying renal abnormalities. Am J Dis Child. 1992 Oct. 146 (10):1181-4. [Medline].

3. Saari-Kemppainen A, Karjalainen O, Ylöstalo P, Heinonen OP. Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet. 1990 Aug 18. 336 (8712):387-91. [Medline].

4. Freedman AL, Johnson MP, Gonzalez R. Fetal therapy for obstructive uropathy: past, present.future?. Pediatr Nephrol. 2000 Feb. 14(2):167-76. [Medline].

5. Harding LJ, Malone PS, Wellesley DG. Antenatal minimal hydronephrosis: is its follow-up an unnecessary cause of concern?. Prenat Diagn. 1999 Aug. 19 (8):701-5. [Medline].

6. Nguyen HT, Benson CB, Bromley B, Campbell JB, Chow J, Coleman B, et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr Urol. 2014 Dec. 10 (6):982-98. [Medline]. [Full Text].

7. Potter EL. Normal and Abnormal Development of the Kidney. Chicago: Year Book Medical Publishers; 1972.

8. Bernstein J. A classification of renal cysts. Gardner KD, ed. Cystic Diseases of the Kidney. New York: John Wiley & Sons; 1976. 7.

9. Mackie GG, Stephens FD. Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice. J Urol. 1975 Aug. 114 (2):274-80. [Medline].

10. Chevalier RL, Chung KH, Smith CD, Ficenec M, Gomez RA. Renal apoptosis and clusterin following ureteral obstruction: the role of maturation. J Urol. 1996 Oct. 156 (4):1474-9. [Medline].

11. Chevalier RL, Gomez RA, Jones CE. Developmental determinants of recovery after relief of partial ureteral obstruction. Kidney Int. 1988 Apr. 33(4):775-81. [Medline].

12. Josephson S. Suspected pyelo-ureteral junction obstruction in the fetus: when to do what? II. Experimental viewpoints. Eur Urol. 1991. 19(2):132-8. [Medline].

13. Lee RS, Cendron M, Kinnamon DD, Nguyen HT. Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis. Pediatrics. 2006 Aug. 118 (2):586-93. [Medline].

14. Thomas DF. Fetal uropathy. Br J Urol. 1990 Sep. 66(3):225-31. [Medline].

15. Chiodini B, Ghassemi M, Khelif K, Ismaili K. Clinical Outcome of Children With Antenatally Diagnosed Hydronephrosis. Front Pediatr. 2019. 7:103. [Medline]. [Full Text].

16. Madarikan BA, Hayward C, Roberts GM, Lari J. Clinical outcome of fetal uropathy. Arch Dis Child. 1988 Aug. 63(8):961-3. [Medline].

17. Ransley PG, Manzoni GA. Postnatal management of UPJ obstruction detected antenatally. Dialogues Ped Urol. 1985. 8:6.

18. Reznik VM, Murphy JL, Mendoza SA, Griswold WR, Packer MG, Kaplan GW. Follow-up of infants with obstructive uropathy detected in utero and treated surgically postnatally. J Pediatr Surg. 1989 Dec. 24 (12):1289-92. [Medline].

19. Hobbins JC, Romero R, Grannum P, Berkowitz RL, Cullen M, Mahoney M. Antenatal diagnosis of renal anomalies with ultrasound. I. Obstructive uropathy. Am J Obstet Gynecol. 1984 Apr 1. 148 (7):868-77. [Medline].

20. Bastide A, Manning F, Harman C, Lange I, Morrison I. Ultrasound evaluation of amniotic fluid: outcome of pregnancies with severe oligohydramnios. Am J Obstet Gynecol. 1986 Apr. 154 (4):895-900. [Medline].

21. Barss VA, Benacerraf BR, Frigoletto FD Jr. Second trimester oligohydramnios, a predictor of poor fetal outcome. Obstet Gynecol. 1984 Nov. 64(5):608-10. [Medline].

22. Wigglesworth JS, Desai R. Is fetal respiratory function a major determinant of perinatal survival?. Lancet. 1982 Jan 30. 1(8266):264-7. [Medline].

23. Mandell J, Peters CA, Estroff JA, Benacerraf BR. Late onset severe oligohydramnios associated with genitourinary abnormalities. J Urol. 1992 Aug. 148(2 Pt 2):515-8. [Medline].

24. Reuss A, Wladimiroff JW, Stewart PA, Scholtmeijer RJ. Non-invasive management of fetal obstructive uropathy. Lancet. 1988 Oct 22. 2 (8617):949-51. [Medline].

25. Glick PL, Harrison MR, Golbus MS, Adzick NS, Filly RA, Callen PW, et al. Management of the fetus with congenital hydronephrosis II: Prognostic criteria and selection for treatment. J Pediatr Surg. 1985 Aug. 20 (4):376-87. [Medline].

26. Burghard R, Gordjani N, Leititis J, Bald R. Protein analysis in amniotic fluid and fetal urine for the assessment of fetal renal function and dysfunction. Fetal Ther. 1987. 2 (4):188-96. [Medline].

27. Johnson MP, Bukowski TP, Reitleman C, Isada NB, Pryde PG, Evans MI. In utero surgical treatment of fetal obstructive uropathy: a new comprehensive approach to identify appropriate candidates for vesicoamniotic shunt therapy. Am J Obstet Gynecol. 1994 Jun. 170 (6):1770-6; discussion 1776-9. [Medline].

28. Coplen DE. Prenatal Management of Hydronephrosis. AUA Update Series; 2000. Vol 19:

29. Garrett WJ, Grunwald G, Robinson DE. Prenatal diagnosis of fetal polycystic kidney by ultrasound. Aust N Z J Obstet Gynaecol. 1970 Feb. 10(1):7-9. [Medline].

30. Stocks A, Richards D, Frentzen B, Richard G. Correlation of prenatal renal pelvic anteroposterior diameter with outcome in infancy. J Urol. 1996 Mar. 155 (3):1050-2. [Medline].

31. Grignon A, Filion R, Filiatrault D, Robitaille P, Homsy Y, Boutin H, et al. Urinary tract dilatation in utero: classification and clinical applications. Radiology. 1986 Sep. 160 (3):645-7. [Medline].

32. Corteville JE, Gray DL, Crane JP. Congenital hydronephrosis: correlation of fetal ultrasonographic findings with infant outcome. Am J Obstet Gynecol. 1991 Aug. 165(2):384-8. [Medline].

33. Nguyen HT, Herndon CD, Cooper C, Gatti J, Kirsch A, Kokorowski P, et al. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol. 2010 Jun. 6 (3):212-31. [Medline].

34. Nguyen HT, Benson CB, Bromley B, Campbell JB, Chow J, Coleman B, et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr Urol. 2014 Dec. 10 (6):982-98. [Medline]. [Full Text].

35. Dos Santos J, Parekh RS, Piscione TD, Hassouna T, Figueroa V, Gonima P, et al. A New Grading System for the Management of Antenatal Hydronephrosis. Clin J Am Soc Nephrol. 2015 Oct 7. 10 (10):1783-90. [Medline]. [Full Text].

36. Kiener TA, Wohlmuth C, Schimke C, Brandtner MG, Wertaschnigg D. Ultrasound Markers in Fetal Hydronephrosis to Predict Postnatal Surgery. Ultraschall Med. 2018 Jul 5. [Medline].

37. Maizels M, Alpert SA, Houston JT, Sabbagha RE, Parilla BV, MacGregor SN. Fetal bladder sagittal length: a simple monitor to assess normal and enlarged fetal bladder size, and forecast clinical outcome. J Urol. 2004 Nov. 172 (5 Pt 1):1995-9. [Medline].

38. Dewan PA, Moon D, Anderson K. Presence of the eggshell sign in obstructive uropathy. Urology. 2002 Feb. 59 (2):287-9. [Medline].

39. Crombleholme TM, Harrison MR, Golbus MS, Longaker MT, Langer JC, Callen PW, et al. Fetal intervention in obstructive uropathy: prognostic indicators and efficacy of intervention. Am J Obstet Gynecol. 1990 May. 162 (5):1239-44. [Medline].

40. Chalmers DJ, Meyers ML, Brodie KE, Palmer C, Campbell JB. Inter-rater reliability of the APD, SFU and UTD grading systems in fetal sonography and MRI. J Pediatr Urol. 2016 Oct. 12 (5):305.e1-305.e5. [Medline].

41. Biedermann KJ. [Indications of fetal chromosome abnormalities in 1st trimester ultrasound]. Praxis (Bern 1994). 2001 May 3. 90(18):779-83. [Medline].

42. Parano E, Falcidia E, Grillo A, Pavone P, Cutuli N, Takabayashi H, et al. Noninvasive prenatal diagnosis of chromosomal aneuploidies by isolation and analysis of fetal cells from maternal blood. Am J Med Genet. 2001 Jul 1. 101 (3):262-7. [Medline].

43. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol. 2001 Jul. 32 (1):76-91. [Medline].

44. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 1995 Jul. 173(1):322-35. [Medline].

45. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2000. (2):CD000065. [Medline].

46. Halliday HL, Ehrenkranz RA. Early postnatal (Cochrane Database Syst Rev</i>. 2000. (2):CD001146. [Medline].

47. Halliday HL, Ehrenkranz RA. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2001. 2:CD001145. [Medline].

48. Halliday HL, Ehrenkranz RA. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2000. (2):CD001144. [Medline].

49. Yoshimura S, Masuzaki H, Gotoh H, Fukuda H, Ishimaru T. Ultrasonographic prediction of lethal pulmonary hypoplasia: comparison of eight different ultrasonographic parameters. Am J Obstet Gynecol. 1996 Aug. 175 (2):477-83. [Medline].

50. Maayan-Metzger A, Lotan D, Jacobson JM, Raviv-Zilka L, Ben-Shlush A, Kuint J, et al. The yield of early postnatal ultrasound scan in neonates with documented antenatal hydronephrosis. Am J Perinatol. 2011 Sep. 28(8):613-8. [Medline].

51. Passerotti CC, Kalish LA, Chow J, Passerotti AM, Recabal P, Cendron M, et al. The predictive value of the first postnatal ultrasound in children with antenatal hydronephrosis. J Pediatr Urol. 2011 Apr. 7(2):128-36. [Medline].

52. Harrison MR, Golbus MS, Filly RA, Callen PW, Katz M, de Lorimier AA, et al. Fetal surgery for congenital hydronephrosis. N Engl J Med. 1982 Mar 11. 306 (10):591-3. [Medline].

53. Ferrer F, McKenna PH. Prenatal and postnatal urologic emergencies. Docimo SG, Canning D, Khoury A, Salle JLP, eds. The Kelalis-King-Belman Textbook of Clinical Pediatric Urology. 6th ed. Boca Raton, FL: CRC Press; 2019. 100-47.

54. Yeung CK, Chowdhary SK, Sreedhar B. Minimally Invasive Management for Vesicoureteral Reflux in Infants and Young Children. Clin Perinatol. 2017 Dec. 44 (4):835-849. [Medline].

55. Quintero RA, Hume R, Smith C, Johnson MP, Cotton DB, Romero R, et al. Percutaneous fetal cystoscopy and endoscopic fulguration of posterior urethral valves. Am J Obstet Gynecol. 1995 Jan. 172 (1 Pt 1):206-9. [Medline].

56. Vergani P, Locatelli A, Strobelt N, Mariani S, Cavallone M, Arosio P, et al. Amnioinfusion for prevention of pulmonary hypoplasia in second-trimester rupture of membranes. Am J Perinatol. 1997 Jul. 14 (6):325-9. [Medline].

57. Djahangirian O, Young I, Dorgalli C, Bissaillon A, Tran NA, Walia A, et al. Safe discharge parameters for patients with isolated antenatal hydronephrosis. J Pediatr Urol. 2018 Aug. 14 (4):321.e1-321.e5. [Medline].

58. Wiener JS, O'Hara SM. Optimal timing of initial postnatal ultrasonography in newborns with prenatal hydronephrosis. J Urol. 2002 Oct. 168(4 Pt 2):1826-9; discussion 1829. [Medline].

59. Herz D, Merguerian P, McQuiston L. Continuous antibiotic prophylaxis reduces the risk of febrile UTI in children with asymptomatic antenatal hydronephrosis with either ureteral dilation, high-grade vesicoureteral reflux, or ureterovesical junction obstruction. J Pediatr Urol. 2014 Aug. 10 (4):650-4. [Medline].

60. Silay MS, Undre S, Nambiar AK, Dogan HS, Kocvara R, Nijman RJM, et al. Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediatric Urology Guidelines Panel. J Pediatr Urol. 2017 Jun. 13 (3):306-315. [Medline].

Dennis B Liu, MD Attending Physician, Ann and Robert H Lurie Children's Hospital of Chicago

Dennis B Liu, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, American Urological Association, Ohio Urological Society, Societies for Pediatric Urology, Society for Fetal Urology

Disclosure: Nothing to disclose.

John D Edmondson, MD Consulting Staff, Virginia Urology Center

John D Edmondson, MD is a member of the following medical societies: American College of Surgeons, American Association of Clinical Urologists, American Urological Association, Endourological Society

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Harry P Koo, MD Chairman of Urology Division, Director of Pediatric Urology, Professor of Surgery, Virginia Commonwealth University School of Medicine, Medical College of Virginia; Director of Urology, Children's Hospital of Richmond

Harry P Koo, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Surgeons, American Urological Association

Disclosure: Nothing to disclose.

Marc Cendron, MD Associate Professor of Surgery, Harvard School of Medicine; Consulting Staff, Department of Urological Surgery, Children's Hospital Boston

Marc Cendron, MD is a member of the following medical societies: American Academy of Pediatrics, American Urological Association, New Hampshire Medical Society, Societies for Pediatric Urology, Society for Fetal Urology, Johns Hopkins Medical and Surgical Association, European Society for Paediatric Urology

Disclosure: Nothing to disclose.

Martin David Bomalaski, MD, FAAP Pediatric Urologist, Alaska Urology; Clinical Assistant Professor, Seattle Children's Hospital

Martin David Bomalaski, MD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Urological Association

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article